Create a narrative

Lisata Therapeutics Community

NasdaqCM:LSTA Community

1 Narratives written by author
0 Comments on narratives written by author
1 Fair Values set on narratives written by author

Create a narrative

Lisata Therapeutics

AN

AnalystConsensusTarget

Consensus Narrative from 3 Analysts

Certepetide Advancements And Regulatory Approvals Will Set New Care Standards

Key Takeaways Advancements in certepetide and regulatory achievements could expedite market entry, fostering revenue growth and enhancing treatment standards. Strategic partnerships and diversified applications beyond oncology offer new revenue streams and market expansion opportunities, potentially improving margins.

US$17.00

FV

87.6% undervalued

49.38%

Revenue growth p.a.

0

0

1

11 days ago